CORRELATION BETWEEN BASELINE HEALTH-RELATED QUALITY OF LIFE (HRQOL) OR SYMPTOM BURDEN AND CLINICAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) TREATED WITH NILOTINIB OR IMATINIB.
ONCOLOGY NURSING FORUM（2012）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要